BNB PLUS CORP (BNBX)
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
$0.14-12.50%
Close 2026-08-10 · 1-day change
NASDAQFinancialsBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BNBX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -84.7% |
| Our one-year growth estimate | diamond | -43.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 41.0 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers · Company calendar date is not available
BNBX — officer change
Dated 2026-09-03
Director — Robert B. Catell, Joseph D. Ceccoli, Dr. Yacov Shamash, Richard Shorten, Todd Larsen, Lok Lee: Three directors resigned and were immediately replaced by new appointees, including a strategic advisor with significant affiliations to a major shareholder, indicating a board reshuffle rather than a loss of senior executive management.
Why it matters: The company wants to raise $5 million. Success shows good money management.
Supportive ifTotal proceeds from private placements reach or exceed $5 million.
Worry ifTotal money from private placements is still under $5 million without new deals.
Why it matters: The review will decide if BNB Plus can stay listed on Nasdaq. Losing this listing could hurt investor confidence.
Worry ifNasdaq Listing Council grants the request for review and allows BNBX to remain listed.
Less concerning ifThe Nasdaq Listing Council confirms BNBX will only trade on OTCQB.
Why it matters: M&A activity shows growth chances and business plans.
Supportive ifThe company shares news about a new acquisition or partnership for the deal.
Worry ifNo new M&A announcements after the recent deal.
Why it matters: The company aims to raise $5 million. Progress signals financial health and strategy success.
Supportive ifThe company raises at least $5 million through private placements by the end of Q3 2026.
Worry ifThe company raises less than $2.5 million through private placements by the end of Q3 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$384 on $10,000 · ±3.8% | How much price usually moves either way. |
| Bad day | $1,386 loss on $10,000 · 13.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,857 loss on $10,000 · 98.6% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Staying profitable would help the strategic review. It would also show improvements in operations.
Supportive ifLineaRx reports it made a profit in Q3 FY2026.
Worry ifLineaRx reports a return to losses in Q3 FY2026.
Why it matters: It is important to follow rules to keep the company's listing.
Worry ifThe company shares a plan to meet Nasdaq rules.
Less concerning ifThe company does not give updates or misses deadlines.
Why it matters: The strategic review may lead to new partnerships or ways to make money. This could affect growth.
Supportive ifThere may be news about a partnership or a plan to make money with LineaRx.
Worry ifNo updates or progress on the strategic review are expected in the next quarter.
Why it matters: The outcome will determine if BNB Plus can stay listed on Nasdaq or not. A favorable review could restore investor confidence.
Supportive ifThe Nasdaq Listing Council accepts the review request. They decide to reverse the delisting.
Worry ifThe Nasdaq Listing Council upholds the delisting decision. This means trading continues only on OTCQB.
Why it matters: This financing is crucial for BNB Plus to support its strategic review and operations. Success may improve liquidity.
Supportive ifTotal proceeds from the financing reach $5 million as planned.
Worry ifThe financing does not secure the expected $5 million. This limits the funds for operations.
Why it matters: The strategic review will guide future business plans. Positive news could help investor trust.
Supportive ifThe company shares a clear plan from the review. This includes possible partnerships.
Worry ifThe review does not provide useful results. The company lacks a clear strategy.
Why it matters: Revenue trends will show if the company can recover from recent declines. This is key for investor sentiment.
Watch forQ3 revenue rises from $605K. This shows signs of recovery.
Also watch forQ3 revenue falls again from $605K. This shows ongoing challenges.